The Impact of Humira Biosimilars: 5 Factors That Will Reduce Payer Costs
The use of biosimilar products in lieu of originator biologic products has been a hot topic of discussion since the…
News
The Latest from Expion Health
Biosimilars 101
The biologics market could see some significant changes with the current and upcoming interchangeability approvals of several biosimilar products. Let’s…
Expion Health Wins Best Tech For Good
Tech in Motion has named Expion Health as Chicago’s Best Tech for Good in this year’s Timmy Awards, recognizing the…
Expion Health Named Top 100 Healthcare Technology Companies
Expion Health has been named one of the Top 100 Healthcare Technology Companies for 2022 by The Healthcare Technology Report. The…
Expion Health Achieves HITRUST CSF® Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements
HITRUST CSF Certification validates Expion Health is committed to meeting key regulations and protecting sensitive information. GAITHERSBURG, MD — Expion…
Expion Health continues to expand offering with acquisition of National Bill Audit Services
GAITHERSBURG, MD — Expion Health is excited to announce the acquisition of National Bill Audit Services (NBAS) as part of…
Fee Negotiation: Controlling Out-of-Network Claims Costs Following the No Surprises Act
On December 27, 2020, H.R.133 — the FY2021 Omnibus Appropriations Bill — was signed into law. Embedded within the nearly…
© 2024 Expion Health | Privacy Policy | User Aggreement
